David Lamond, Director at Cortexyme, Inc. (CRTX), bought 84,711 shares at $46.30 ($4.7M) on 2020-05-15, disclosed to the SEC on 2020-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.30 | 1,263 | $58K | 1.2% |
| 2 | $46.30 | 1,263 | $58K | 1.2% |
| 3 | $48.37 | 985 | $48K | 1.0% |
| 4 | $48.96 | 1,600 | $78K | 1.7% |
| 5 | $50.71 | 1,000 | $51K | 1.1% |
| 6 | $52.20 | 500 |
| $26K |
| 0.6% |
| 7 | $53.10 | 100 | $5K | 0.1% |
| 8 | $54.09 | 400 | $22K | 0.5% |
| 9 | $55.42 | 5,906 | $327K | 6.9% |
| 10 | $55.42 | 5,906 | $327K | 6.9% |
| 11 | $56.42 | 32,894 | $1.9M | 39.4% |
| 12 | $56.42 | 32,894 | $1.9M | 39.4% |
| Total | $55.64 avg | 84,711 | $4.7M | 100% |
| Filing → |
| QNCX | BUY | 2023-12-01 | $41K | — | Filing → |
| QNCX | BUY | 2023-08-31 | $216K | — | Filing → |
| QNCX | BUY | 2023-08-17 | $620K | — | Filing → |